Physician

Steven B Weinsier, MD

According to 2025 Medicare claims, Steven Weinsier, MD (NPI: 1336366897) practices cardiology in the Amherst Town-Northampton, MA market, with the plurality of this provider's patient population coming from Hampshire, MA. This provider's primary affiliated billing organization is MASS GENERAL BRIGHAM MEDICAL GROUP WESTERN MASSACHUSETTS INC (NPI: 1295787919; TIN: 043194547) and primary practice location at 01060-4272. Weinsier is affiliated with the Mass General Brigham ACO, LLC (ACO ID: A4641), participating under the MSSP model.

Weinsier's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 3,477 traditional Medicare patients, billed 7,924 HCPCS/CPT codes, and received $380,751 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 6,781 prescription claims across 1,190 beneficiaries totaling $1,487,959 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 64 records totaling $1,257. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $68,110 to $1,487,959. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,421	3,615	$256,234
2016	1,630	5,477	$465,586
2017	1,628	5,002	$416,255
2018	2,483	7,325	$547,102
2019	2,228	7,149	$593,668
2020	2,539	7,300	$522,353
2021	2,889	7,862	$567,515
2022	3,226	8,176	$511,226
2023	3,124	6,996	$366,636
2024	3,477	7,924	$380,751

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	226	1,416	$68,110
2016	277	2,050	$88,330
2017	375	2,594	$115,041
2018	523	3,249	$234,409
2019	617	3,504	$341,916
2020	763	3,846	$515,108
2021	1,091	5,478	$850,147
2022	1,242	6,128	$1,104,554
2023	1,200	6,472	$1,379,837
2024	1,190	6,781	$1,487,959

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	933	1,211	$92
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	630	686	$62
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	193	203	$13
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	593	612	$11
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	1,903	2,872	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	497	35,535	$663,759
Xarelto	Rivaroxaban	182	14,405	$253,650
Entresto	Sacubitril/Valsartan	117	6,623	$143,785
Repatha Sureclick	Evolocumab	102	5,099	$98,675
Jardiance	Empagliflozin	49	2,790	$53,488

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	64	$1,257	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Steven B. Weinsier, MD?

Tedicare shows public-source Medicare data for Steven B. Weinsier, MD (NPI 1336366897), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Steven B. Weinsier, MD have ACO affiliation data?

Steven B. Weinsier, MD is shown with ACO affiliation data for Mass General Brigham ACO, LLC (MSSP, ACO ID A4641).

What billing organization is linked to Steven B. Weinsier, MD?

Steven B. Weinsier, MD is linked to MASS GENERAL BRIGHAM MEDICAL GROUP WESTERN MASSACHUSETTS INC (billing NPI 1295787919) in the available physician profile data.

Does Steven B. Weinsier, MD have Open Payments data?

Steven B. Weinsier, MD has 64 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.